Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

Core Insights - Kymera Therapeutics, Inc. is set to report its third quarter 2025 financial results on November 4, 2025, and will host a video conference call at 8:30 a.m. ET on the same day [1] Company Overview - Kymera Therapeutics is a clinical-stage biotechnology company focused on targeted protein degradation (TPD) to develop innovative medicines for immunological diseases [3] - The company aims to create a pipeline of oral small molecule degraders that can provide effective therapies for patients, addressing disease targets that are not accessible with traditional therapeutics [3] - Founded in 2016, Kymera has been recognized as one of Boston's top workplaces in recent years [3]